Centene (NYSE:CNC) had its price objective lifted by Cantor Fitzgerald from $115.00 to $125.00 in a research note released on Wednesday morning. The brokerage currently has an overweight rating on the stock.

Other equities analysts also recently issued reports about the company. Jefferies Group upped their target price on Centene from $98.00 to $112.00 and gave the company a buy rating in a research report on Friday, October 13th. Piper Jaffray Companies reissued a buy rating and issued a $134.00 target price on shares of Centene in a research report on Monday, December 18th. Oppenheimer reissued a buy rating and issued a $111.00 target price on shares of Centene in a research report on Friday, December 15th. Cowen reaffirmed a buy rating and issued a $115.00 price target on shares of Centene in a report on Tuesday, October 24th. Finally, ValuEngine raised shares of Centene from a hold rating to a buy rating in a report on Sunday, December 31st. Three equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the stock. Centene presently has a consensus rating of Buy and a consensus price target of $108.63.

Centene (NYSE:CNC) opened at $104.38 on Wednesday. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.93 and a quick ratio of 0.99. Centene has a 12-month low of $65.03 and a 12-month high of $112.42. The stock has a market capitalization of $17,889.97, a price-to-earnings ratio of 22.26, a P/E/G ratio of 1.04 and a beta of 0.71.

Centene (NYSE:CNC) last released its earnings results on Tuesday, February 6th. The company reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.94 by $0.03. Centene had a return on equity of 13.68% and a net margin of 1.71%. The firm had revenue of $12.81 billion for the quarter, compared to the consensus estimate of $12.25 billion. During the same period in the prior year, the firm earned $1.19 EPS. The firm’s revenue was up 7.5% on a year-over-year basis. research analysts predict that Centene will post 7.15 earnings per share for the current year.

In other news, EVP Jesse N. Hunter sold 10,000 shares of the stock in a transaction dated Tuesday, December 19th. The shares were sold at an average price of $98.73, for a total transaction of $987,300.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Robert K. Ditmore sold 8,750 shares of the stock in a transaction dated Monday, January 8th. The stock was sold at an average price of $104.30, for a total transaction of $912,625.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 23,750 shares of company stock worth $2,400,475. Corporate insiders own 3.00% of the company’s stock.

A number of institutional investors have recently modified their holdings of the stock. Elk Creek Partners LLC lifted its stake in Centene by 11.5% in the 3rd quarter. Elk Creek Partners LLC now owns 5,264 shares of the company’s stock valued at $509,000 after buying an additional 542 shares in the last quarter. Mutual of America Capital Management LLC lifted its stake in Centene by 1.6% in the 3rd quarter. Mutual of America Capital Management LLC now owns 34,834 shares of the company’s stock valued at $3,371,000 after buying an additional 562 shares in the last quarter. Savant Capital LLC lifted its stake in Centene by 19.7% in the 3rd quarter. Savant Capital LLC now owns 3,580 shares of the company’s stock valued at $346,000 after buying an additional 590 shares in the last quarter. New Mexico Educational Retirement Board lifted its stake in Centene by 3.8% in the 4th quarter. New Mexico Educational Retirement Board now owns 16,600 shares of the company’s stock valued at $1,675,000 after buying an additional 600 shares in the last quarter. Finally, CIBC Asset Management Inc lifted its stake in Centene by 4.0% in the 3rd quarter. CIBC Asset Management Inc now owns 16,475 shares of the company’s stock valued at $1,594,000 after buying an additional 630 shares in the last quarter. 92.41% of the stock is currently owned by hedge funds and other institutional investors.

WARNING: “Centene (CNC) Price Target Increased to $125.00 by Analysts at Cantor Fitzgerald” was first published by Daily Political and is the property of of Daily Political. If you are viewing this news story on another site, it was stolen and reposted in violation of international trademark & copyright law. The original version of this news story can be read at https://www.dailypolitical.com/2018/02/08/centene-cnc-price-target-increased-to-125-00-by-analysts-at-cantor-fitzgerald.html.

About Centene

Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company’s Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children’s Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace.

Analyst Recommendations for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.